ADJUVANT OF NOVEL CORONAVIRUS VACCINE AND USE THEREOF, AND BIVALENT RECOMBINANT VACCINE OF NOVEL CORONAVIRUS
Disclosed in the present invention are an adjuvant for a novel coronavirus COVID-19 vaccine, and a developed bivalent vaccine thereof which contains antigens of a novel coronavirus epidemic HuB strain and a South African mutant strain B.1.351. La présente invention concerne un adjuvant pour un vacci...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
28.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed in the present invention are an adjuvant for a novel coronavirus COVID-19 vaccine, and a developed bivalent vaccine thereof which contains antigens of a novel coronavirus epidemic HuB strain and a South African mutant strain B.1.351.
La présente invention concerne un adjuvant pour un vaccin contre le coronavirus de la COVID-19, et un vaccin bivalent associé qui contient des antigènes d'une souche HuB de coronavirus et d'une souche mutante B.1.351 d'Afrique du sud.
本发明公开一种用于新型冠状病毒COVID-19疫苗的佐剂,及其含有新型冠状病毒流行HuB毒株和南非突变毒株B.1.351抗原研制的二价疫苗。 |
---|---|
Bibliography: | Application Number: WO2022CN94484 |